RPRX reports Wednesday, Feb 10, 2027, before the open. After the last 4 reports the stock moved +1.7%, +0.5%, +0.6%, +0.1% the next day.
RPRX is expected to report on Wednesday, Feb 10, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 4, 2026 | 1.18 | 1.21 | +1.7% | +4.6% |
| Aug 5, 2026 | 1.27 | 1.32 | +0.5% | +0.5% |
| May 6, 2026 | 1.18 | 1.30 | +0.6% | +2.5% |
| Feb 11, 2026 | 1.33 | 1.47 | +0.1% | +2.6% |
| Nov 5, 2025 | 1.04 | 1.17 | +6.8% | +3.0% |
| Aug 6, 2025 | 1.03 | 1.14 | −2.1% | −5.4% |
| May 8, 2025 | 0.95 | 1.06 | +1.1% | −1.4% |
| Feb 11, 2025 | 1.05 | 1.15 | +1.7% | +3.6% |
Average move the next trading day over the last 8 reports: ±1.8% (7 of 8 up).
RPRX is in an uptrend, momentum soft. $70 is the level overhead; $62.31 the first support below.
RPRX at $68.45. Nearest resistance $70.00 (+2.3%). Nearest support $62.31 (−9.0%).
RPRX chart, levels and analysis · Latest analysis: Royalty Pharma (RPRX) stock analysis, November 20, 2026: bullish outlook with high conviction · Earnings this week
RPRX is expected to report on Wednesday, Feb 10, 2027, before the open.
RPRX reports before the open, US Eastern time.
After its report on Nov 4, 2026, RPRX moved +1.7% the next trading day.
Over the last 8 reports, RPRX moved 1.8% on average the next trading day, up 7 times out of 8.
Updated Nov 5, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.